Stuart Releases Statement Supporting Federal Combating Illicit Xylazine Act

EDWARDSVILLE, Ill. – State Representative Katie Stuart, D-Edwardsville releases a statement supporting the federal Combating Illicit Xylazine Act and calls on the Illinois House to pass Senate Bill 1773:

“Earlier this month, we watched the Combating Illicit Xylazine Act unanimously pass the federal House of Representatives. Their bill would list xylazine as a Class III controlled substance while still allowing professionals, like veterinarians and biologists, access explicitly for work needs. 

“Xylazine is being used as a low-cost cutting agent, leading to the fentanyl crisis becoming increasingly more deadly. This drug has harmful side effects, like lowering a person’s heart rate and blood pressure to dangerously low levels. It does not respond to opioid reversal medications used when treating fentanyl overdoses, making it difficult to treat. 

“If their act passes the Senate and is signed into law, it will be a clear signal that the drug crisis cannot continue, and it’s time to hold those who profit from these drugs accountable. It’s a clear step in the right direction, and I hope that Illinois will follow the same path.   

“Over the most recent session period, the Illinois Senate passed my legislation, Senate Bill 1773, which would classify xylazine as a Class III controlled substance, while still allowing professionals access. It’s time that the Illinois House of Representatives also passed this bill, so we can send it to the Governor’s desk to be signed into law. With this classification, we would be taking an important step towards saving lives, strengthening public safety, and providing law enforcement with the tools they need to protect our communities.”